MORGAN STANLEY

Position in JSPR — Jasper Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in JSPR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,168,073

-$2,436,631 QoQ

Shares Held

1,333,420

-32.3% QoQ

Ownership

4.76%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. JSPR ranks #245 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,168,073	1,333,420	-32.3%	Shares	Defined	2026-05-15
2025-12-31	$3,604,704	1,969,785	+149.4%	Shares	Defined	2026-05-27
2025-09-30	$1,880,103	789,960	+2.6%	Shares	Defined	2026-05-27
2025-06-30	$4,272,109	769,750	+17.7%	Shares	Defined	2025-08-15
2025-03-31	$2,812,129	653,984	+8.1%	Shares	Defined	2025-05-15
2024-12-31	$12,930,451	604,792	+6.9%	Shares	Defined	2025-05-15
2024-09-30	$10,641,228	565,722	+82.8%	Shares	Defined	2025-05-14
2024-06-30	$7,023,810	309,419	+75.4%	Shares	Defined	2025-05-14
2024-03-31	$5,179,601	176,417	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.